Immunosuppression and Post-transplant Hyperglycemia.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Current Diabetes Reviews

• Publication date

  2015-08-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/1573399811666150331160846PMID 25824238
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Steroid avoidance or withdrawal for kidney transplant recipients.

  2016cited by this paper
• Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients.

  2014cited by this paper
• Diabetes Mellitus in the Transplanted Kidney

  2014cited by this paper
• Long-Term Follow-Up of a Phase III Clinical Trial Comparing Tacrolimus Extended-Release/MMF, Tacrolimus/MMF, and Cyclosporine/MMF in De Novo Kidney Transplant Recipients

  2014cited by this paper
• Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions

  2014cited by this paper
• Glucose Metabolism After Renal Transplantation

  2013cited by this paper
• Calcineurin Inhibitor–Free Mycophenolate Mofetil/Sirolimus Maintenance in Liver Transplantation: The Randomized Spare‐the‐Nephron Trial

  2013cited by this paper
• Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients.

  2013cited by this paper
• Novel views on new-onset diabetes after transplantation: development, prevention and treatment.

  2013cited by this paper
• A Randomized, Open-Label Study of Sirolimus Versus Cyclosporine in Primary De Novo Renal Allograft Recipients

  2013cited by this paper
• Once-Daily Extended-Release Versus Twice-Daily Standard-Release Tacrolimus in Kidney Transplant Recipients: A Systematic Review

  2013cited by this paper
• Screening for New-Onset Diabetes After Kidney Transplantation: Limitations of Fasting Glucose and Advantages of Afternoon Glucose and Glycated Hemoglobin

  2013cited by this paper
• The Higher Diabetogenic Risk of Tacrolimus Depends on Pre‐Existing Insulin Resistance. A Study in Obese and Lean Zucker Rats

  2013cited by this paper
• Steroid avoidance with early intensified dosing of enteric-coated mycophenolate sodium: a randomized multicentre trial in kidney transplant recipients.

  2012cited by this paper
• Association between a common KCNJ11 polymorphism (rs5219) and new-onset posttransplant diabetes in patients treated with Tacrolimus.

  2012cited by this paper
• Very early steroid withdrawal or complete avoidance for kidney transplant recipients: a systematic review.

  2012cited by this paper
• Renal resistive index as a new independent risk factor for new‐onset diabetes mellitus after kidney transplantation

  2012cited by this paper
• Everolimus plus early tacrolimus minimization: a phase III, randomized, open‐label, multicentre trial in renal transplantation

  2012cited by this paper
• Association of Genetic Polymorphisms of Interleukins With New-Onset Diabetes After Transplantation in Renal Transplantation

  2012cited by this paper
• Alemtuzumab Induction Therapy in Kidney Transplantation: A Systematic Review and Meta-Analysis

  2012cited by this paper
• New‐Onset Diabetes After Kidney Transplantation—Changes and Challenges

  2012cited by this paper
• Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity.

  2012cited by this paper
• Alcohol Consumption, New Onset of Diabetes After Transplantation, and All-Cause Mortality in Renal Transplant Recipients

  2011cited by this paper
• Meta-analysis of calcineurin-inhibitor-sparing regimens in kidney transplantation.

  2011cited by this paper
• The ORION Study: Comparison of Two Sirolimus‐Based Regimens versus Tacrolimus and Mycophenolate Mofetil in Renal Allograft Recipients

  2011influential reference
• Steroid avoidance or withdrawal in kidney transplantation

  2011cited by this paper
• Steroid sparing protocols following nonrenal transplants; the evidence is not there. A systematic review and meta‐analysis

  2011cited by this paper
• Everolimus Plus Reduced‐Exposure CsA versus Mycophenolic Acid Plus Standard‐Exposure CsA in Renal‐Transplant Recipients

  2010cited by this paper
• Risk Factors for Development of New-Onset Diabetes Mellitus in Adult Heart Transplant Recipients

  2010cited by this paper
• Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study.

  2010cited by this paper
• Predicting Coronary Heart Disease after Kidney Transplantation: Patient Outcomes in Renal Transplantation (PORT) Study

  2010cited by this paper
• Risk factors for new-onset diabetes after kidney transplantation

  2010cited by this paper
• Steroid Avoidance or Withdrawal After Renal Transplantation Increases the Risk of Acute Rejection but Decreases Cardiovascular Risk. A Meta-Analysis

  2010cited by this paper
• A Systematic Review on Steroid Withdrawal Between 3 and 6 Months After Kidney Transplantation

  2010cited by this paper
• Impaired glucose homeostasis in renal transplant recipients receiving basiliximab.

  2010cited by this paper
• Everolimus With Very Low-Exposure Cyclosporine A in De Novo Kidney Transplantation: A Multicenter, Randomized, Controlled Trial

  2009cited by this paper
• Steroid avoidance or withdrawal for kidney transplant recipients.

  2009cited by this paper
• Posttransplantation Hypomagnesemia and Its Relation with Immunosuppression as Predictors of New‐Onset Diabetes after Transplantation

  2009cited by this paper
• Mammalian target of rapamycin and diabetes: what does the current evidence tell us?

  2009cited by this paper
• mTORC1 Activation Regulates β-Cell Mass and Proliferation by Modulation of Cyclin D2 Synthesis and Stability*

  2009cited by this paper
• A Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Comparing Early (7 Day) Corticosteroid Cessation Versus Long-Term, Low-Dose Corticosteroid Therapy

  2008cited by this paper
• Sirolimus is associated with new-onset diabetes in kidney transplant recipients.

  2008influential reference
• Steroid avoidance in liver transplantation: Meta‐analysis and meta‐regression of randomized trials

  2008cited by this paper
• Nonimmunosuppressive effects of mammalian target of rapamycin inhibitors.

  2008cited by this paper
• Sub-chronic stimulation of glucocorticoid receptor impairs and mineralocorticoid receptor protects cytosolic Ca2+ responses to glucose in pancreatic beta-cells.

  2008cited by this paper
• Reduced Incidence of New-Onset Posttransplantation Diabetes Mellitus During the Last Decade

  2007cited by this paper
• Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus

  2007cited by this paper
• Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients.

  2006cited by this paper
• Dexamethasone Induces Cell Death in Insulin-Secreting Cells, an Effect Reversed by Exendin-4

  2006cited by this paper
• Immunosuppressive drug-induced diabetes.

  2006cited by this paper
• The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events.

  2006cited by this paper
• Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function.

  2006cited by this paper
• Cyclosporin versus tacrolimus for liver transplanted patients.

  2006cited by this paper
• Corticosteroid-Free Immunosuppression with Tacrolimus, Mycophenolate Mofetil, and Daclizumab Induction in Renal Transplantation

  2005cited by this paper
• Adenovirus-mediated XIAP gene transfer reverses the negative effects of immunosuppressive drugs on insulin secretion and cell viability of isolated human islets.

  2005cited by this paper
• Serum- and glucocorticoid-inducible kinase 1 (SGK1) mediates glucocorticoid-induced inhibition of insulin secretion.

  2005cited by this paper
• Evaluating mechanisms of post-transplant diabetes mellitus.

  2004cited by this paper
• Inhibition of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus in primary, mature islets of transgenic mice.

  2003cited by this paper
• The effects of acute and chronic dexamethasone administration on insulin binding to isolated rat hepatocytes and adipocytes.

  1975cited by this paper
• Effect of dexamethasone on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes.

  1975cited by this paper

• β-Cell Benchmarks: Defining Predictive Outcomes in Islet Transplantation

  2025cites this paper
• Exploring Kaempferol's Potential Immunomodulation and Alleviation of Tacrolimus-Induced Hyperglycemia

  2025cites this paper
• Diabetic Kidney Disease in Post-Kidney Transplant Patients

  2024cites this paper
• Novel Therapeutic Agents for Cardiometabolic Risk Mitigation in Heart Transplant Recipients.

  2024cites this paper
• Long-term Prolonged-release Tacrolimus-based Immunosuppression in De Novo Kidney Transplant Recipients: 5-Y Prospective Follow-up of Patients in the ADVANCE Study

  2023cites this paper
• Immunosuppressive Agents—Effects on the Cardiovascular System and Selected Metabolic Aspects: A Review

  2023cites this paper
• A randomized trial of continuous glucose monitoring to improve post‐transplant glycemic control

  2023cites this paper
• Dyslipidemia in Transplant Patients: Which Therapy?

  2022cites this paper
• The Effect of Voriconazole on Tacrolimus in Kidney Transplantation Recipients: A Real-World Study

  2022cites this paper
• Endocrine Sequelae in 157 Pediatric Survivors of Hematopoietic Stem Cell Transplantation (HSCT)

  2022cites this paper
• Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Use for Atherogenic Dyslipidemia in Solid Organ Transplant Patients

  2022cites this paper
• Risk of New-Onset Diabetes Mellitus Associated with Antirheumatic Drugs in Patients with Rheumatoid Arthritis: A Nationwide Population Study

  2022cites this paper
• Management of post-transplant diabetes mellitus: an opportunity for novel therapeutics

  2021cites this paper
• The relationship between periodontal status and hyperglycemia after kidney transplantation

  2021cites this paper
• Late Effects After Haematopoietic Stem Cell Transplantation in ALL, Long-Term Follow-Up and Transition: A Step Into Adult Life

  2021cites this paper
• Nonalcoholic Fatty Liver Disease in the Post Liver Transplant Patient

  2020cites this paper
• Risk Factors in and Long-Term Survival of Patients with Post-Transplantation Diabetes Mellitus: A Retrospective Cohort Study

  2020cites this paper
• Endocrine disorders after heart transplantation: national cohort study

  2020cites this paper
• pre-existing diabetes and PTDM in kidney transplant recipients: how to handle immunosuppression

  2020cites this paper
• A systematic approach to the endocrine care of survivors of pediatric hematopoietic stem cell transplantation

  2020cites this paper
• Management of new onset diabetes after transplantation (NODAT) with use of novel algorithm

  2019cites this paper
• Beta cells in type 1 diabetes: mass and function; sleeping or dead?

  2019cites this paper
• Anti-Diabetogenic Properties of Mineralocorticoid Receptor Antagonists: Implications for Enhanced Safety and Efficacy of Post-Transplantation Pharmacotherapies

  2019cites this paper
• Malglycemia is associated with poor outcomes in pediatric and adolescent hematopoietic stem cell transplant patients.

  2019cites this paper
• Management of dyslipidemia in adult solid organ transplant recipients.

  2019cites this paper
• Hyperglycemia During Childhood Cancer Therapy: Incidence, Implications, and Impact on Outcomes.

  2019cites this paper
• Herausfordernde Blutzuckereinstellung bei einer frisch lebertransplantierten Diabetikerin in der Anschlussrehabilitation

  2019cites this paper
• Role of sex in post-transplant diabetes mellitus development: Are men and women equal?

  2019cites this paper
• Disseminated mucormycosis masquerading as rejection early after orthotopic heart transplantation

  2018cites this paper
• Diabetes in Kidney Transplant Recipients

  2018cites this paper
• Post-transplantation diabetes in kidney transplant recipients: an update on management and prevention

  2018cites this paper
• Genetic risk factors for post-transplantation diabetes mellitus in Chinese Han renal allograft recipients treated with tacrolimus.

  2018cites this paper
• The Fate of Allogeneic Pancreatic Islets following Intraportal Transplantation: Challenges and Solutions

  2018cites this paper
• Inhibition of peptidyl-prolyl cis-trans isomerase B mediates cyclosporin A-induced apoptosis of islet β cells

  2018cites this paper
• Obesidad, diabetes y trasplante

  2017cites this paper
• Impaired mitochondrial calcium uptake caused by tacrolimus underlies beta-cell failure

  2017cites this paper
• Diabetes Mellitus Following Renal Transplantation: Clinical and Pharmacological Considerations for the Elderly Patient

  2017cites this paper
• Diagnostic accuracy of glycated hemoglobin for post‐transplantation diabetes mellitus after kidney transplantation: systematic review and meta‐analysis

  2017cites this paper
• A Prospective Study of Renal Transplant Recipients: A Fall in Insulin Secretion Underpins Dysglycemia After Renal Transplantation

  2016cites this paper
• Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside.

  2016cites this paper
• Post-transplantation diabetes-state of the art.

  2016cites this paper
• TACKLING A BIG PROBLEM WITH LITTLE EVIDENCE: IMPROVING RESEARCH INTO POSTTRANSPLANTATION DIABETES.

  2016cites this paper
• Characterization of Remitting and Relapsing Hyperglycemia in Post-Renal-Transplant Recipients

  2015cites this paper
• Effect of Demographic and Clinical Factors on New- Onset Diabetes Mellitus after Liver Transplantation in Iranian Patients

  2015cites this paper
• Drugs that Act on the Immune System: Immunosuppressive and Immunostimulatory Drugs

  2015cites this paper
• Diabetes Mellitus and Prediabetes on Kidney Transplant Waiting List- Prevalence, Metabolic Phenotyping and Risk Stratification Approach

  2015cites this paper
• Renal posttransplantation diabetes mellitus: An overview.

  2015cites this paper